JP Patent

JP6602847B2 — デリバリー機能と遺伝子発現制御能を有する一本鎖核酸分子

Assigned to Bonac Corp · Expires 2019-11-06 · 7y expired

What this patent protects

Patent listed against vutrisiran-sodium.

Drugs covered by this patent

Patent Metadata

Patent number
JP6602847B2
Jurisdiction
JP
Classification
—
Expires
2019-11-06
Drug substance claim
No
Drug product claim
No
Assignee
Bonac Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.